UBS Group’s Molecular Templates, Inc. MTEM Stock Holding History

UBS Group’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4	Closed	-$2K	–	9543
2014 Q4	$2K	Buy	+4	New	+$2K	﹤0.01%	9438

Other funds holding MTEM

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UBS Group's MTEM Position: Q4 2024 in Review

UBS Group sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 1 share — an estimated $1 sold.

UBS Group first reported a position in MTEM in Q4 2014 and held it in 36 quarters. The position peaked at $767K in Q4 2019. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

UBS Group reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
UBS Group sold 1 Molecular Templates, Inc. share in Q4 2024, an estimated $1.
UBS Group first reported a position in Molecular Templates, Inc. in Q4 2014 and held it in 36 quarters.
UBS Group's Molecular Templates, Inc. position peaked at $767K in Q4 2019.
3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.